177 related articles for article (PubMed ID: 34913599)
21. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
22. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
23. Adenocarcinoma in Barrett's oesophagus: an overrated risk.
Van der Veen AH; Dees J; Blankensteijn JD; Van Blankenstein M
Gut; 1989 Jan; 30(1):14-8. PubMed ID: 2920919
[TBL] [Abstract][Full Text] [Related]
24. Barrett's oesophagus: an audit of surveillance over a 17-year period.
Gladman L; Chapman W; Iqbal TH; Gearty JC; Cooper BT
Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):271-6. PubMed ID: 16462540
[TBL] [Abstract][Full Text] [Related]
25. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.
Hurschler D; Borovicka J; Neuweiler J; Oehlschlegel C; Sagmeister M; Meyenberger C; Schmid U
Swiss Med Wkly; 2003 Sep; 133(37-38):507-14. PubMed ID: 14652799
[TBL] [Abstract][Full Text] [Related]
26. Barrett oesophagus in 2013: risk stratification and surveillance in Barrett oesophagus.
Gorospe EC; Wang KK
Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):82-4. PubMed ID: 24322896
[TBL] [Abstract][Full Text] [Related]
27. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
28. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
[TBL] [Abstract][Full Text] [Related]
29. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
de Jonge PJ; van Blankenstein M; Looman CW; Casparie MK; Meijer GA; Kuipers EJ
Gut; 2010 Aug; 59(8):1030-6. PubMed ID: 20639249
[TBL] [Abstract][Full Text] [Related]
30. Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial.
Old O; Moayyedi P; Love S; Roberts C; Hapeshi J; Foy C; Stokes C; Briggs A; Jankowski J; Barr H;
J Med Screen; 2015 Sep; 22(3):158-64. PubMed ID: 25767103
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in understanding and preventing oesophageal cancer.
Franklin J; Jankowski J
F1000Res; 2020; 9():. PubMed ID: 32399195
[TBL] [Abstract][Full Text] [Related]
32. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.
Thrift AP
Nat Rev Gastroenterol Hepatol; 2021 Jun; 18(6):432-443. PubMed ID: 33603224
[TBL] [Abstract][Full Text] [Related]
33. The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.
Royston C; Caygill C; Charlett A; Bardhan KD
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1365-1373. PubMed ID: 27571366
[TBL] [Abstract][Full Text] [Related]
34. Barrett's oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review.
Tullie L; Kelay A; Bethell GS; Major C; Hall NJ
BJS Open; 2021 Jul; 5(4):. PubMed ID: 34370830
[TBL] [Abstract][Full Text] [Related]
35. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
[TBL] [Abstract][Full Text] [Related]
36. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus.
El-Serag HB; Naik AD; Duan Z; Shakhatreh M; Helm A; Pathak A; Hinojosa-Lindsey M; Hou J; Nguyen T; Chen J; Kramer JR
Gut; 2016 Aug; 65(8):1252-60. PubMed ID: 26311716
[TBL] [Abstract][Full Text] [Related]
37. Barrett's oesophagus: epidemiology, diagnosis and clinical management.
Whiteman DC; Kendall BJ
Med J Aust; 2016 Oct; 205(7):317-24. PubMed ID: 27681974
[TBL] [Abstract][Full Text] [Related]
38. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
Reid BJ; Li X; Galipeau PC; Vaughan TL
Nat Rev Cancer; 2010 Feb; 10(2):87-101. PubMed ID: 20094044
[TBL] [Abstract][Full Text] [Related]
39. Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance.
Alcedo J; Ferrández A; Arenas J; Sopeña F; Ortego J; Sainz R; Lanas A
Dis Esophagus; 2009; 22(3):239-48. PubMed ID: 19425201
[TBL] [Abstract][Full Text] [Related]
40. Surveillance and screening for Barrett esophagus and adenocarcinoma.
Mashimo H; Wagh MS; Goyal RK
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S33-41. PubMed ID: 15758657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
